BERNADETTE ROJVANIT: Open Payments
NPI 1104487735 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 25 payments from 14 companies in 2025. Trend: 2023 $838 · 2024 $640 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $181 |
| Medtronic, Inc. | 1 | $129 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| Edwards Lifesciences Corporation | 2 | $70 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| Amgen Inc. | 3 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Liquidia Technologies, Inc. | 1 | $21 |
Products named: SYMPLICITY G3, Ozempic, LEQVIO, Wegovy, VERQUVO, REPATHA, PASCAL, ELIQUIS.
Industry payments across AZ — which companies pay providers there.
